ArticleOpen forum infectious diseases2015

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.

Jordan E Lake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.